Brad Robling is a Global Head, Lilly Ventures at Eli Lilly, which invests at seed in life sciences, healthtech.
At firms with a similar stage, sector and check size.
One email when Brad's firm raises a fund, adds a partner or shows new activity.

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.
Send your deckBrad Robling is a Global Head, Lilly Ventures at Eli Lilly, which invests at seed in life sciences, healthtech.
Eli Lilly has not reported a check size. It invests at seed.
A warm intro from a founder Eli Lilly backed works best.
Last updated 2026-10-15. Is this you? Ask for a correction.